APOO / MIC26 (Q9BUR5) — review notes

Human APOO, HGNC:28727, X-linked (Xp22.11), UniProt Q9BUR5 = MIC26_HUMAN, 198 aa,
PANTHER PTHR14564 ("MICOS COMPLEX SUBUNIT MIC26 / MIC27 FAMILY MEMBER"), Pfam PF09769
(ApoO), InterPro IPR019166 / IPR033182. Accession verified: the fetched record's ID line is
ID MIC26_HUMAN Reviewed; 198 AA. — the expected protein, not a merged
accession pointing elsewhere.

Two names, one protein, two incompatible identities in the literature: the plasma
apolipoprotein "ApoO" of 2006, and the MICOS subunit MIC26 of 2013 onwards. Almost every
curation question on this gene turns on which of the two the annotation rests on.


1. The two identities, and how the field resolved them

1.1 The apolipoprotein identity (2006)

APOO was named from a dog obesity cardiac-transcriptome screen and characterised as a secreted
chondroitin-sulfate proteoglycan found in lipoprotein fractions
PMID:16956892,
glycosylated
PMID:16956892,
and functional in cholesterol handling
PMID:16956892.
Everything in that paper about secretion, glycosylation and lipoprotein association was read
off a 55 kDa immunoreactive band, against a recombinant protein of 22 kDa.

1.2 The MICOS identity (2013-2015)

Complexome profiling of mammalian mitochondria placed APOO and APOOL in the Mitofilin/MINOS
(now MICOS) complex PMID:23704930, and three 2015 papers established MIC26 as a bona fide
subunit:

Koob et al. tried to reconcile the two identities by proposing three coexisting forms
PMID:25764979.
That three-form model is the direct source of the Secreted, Golgi apparatus membrane and
Endoplasmic reticulum membrane lines still in the UniProt record, and hence of six GOA rows:
three IDAs cited to this paper and the three GO_REF:0000044 IEAs generated from those UniProt
lines.

1.3 The three-form model was retracted in substance in 2023

Lubeck et al. — from the same laboratory, with Anand and Reichert co-authors on both the
2015 and the 2023 paper — went back with the controls the earlier work lacked:

PMID:37279200

The 55 kDa band survives knockdown with three siRNAs, survives CRISPR knockout in four human
cell lines (HEK293, HepG2, HeLa, HAP1), is not produced by GFP- or myc-tagged MIC26, is
unaffected by mutating the predicted glycosylation sites
PMID:37279200,
and contains no MIC26 peptides
PMID:37279200.
Their conclusion:

PMID:37279200

They also note the negative external check that had been available all along
PMID:37279200.

The tell was already visible in the 2015 companion data paper, unremarked
PMID:26217777
— an antibody signal that does not go down when the gene is knocked down is, in hindsight, the
definition of non-specific.

Curation consequence. Eight GOA rows assert a secretory/ER/Golgi identity: GO:0005576 x4,
GO:0000139 x2 and GO:0005789 x2 — the six above plus the GO:0005576 EXP on PMID:16956892
and the GO:0005576 ISS from pig. All eight trace to the 55 kDa band and all eight are marked
REMOVE (the ninth REMOVE in this review is the unrelated SAM-complex row, §4). This is not second-guessing a curator from an
abstract: it is following the primary literature to the paper, by the original authors, that
withdrew the observation using knockouts.

1.4 Sequence-level corroboration (this review's bioinformatics)

UniProt's SIGNAL 1..25 on Q9BUR5 carries ECO:0000255 — prediction only. The paralogue
Q6UXV4/MIC27, same family, same complex, same membrane, is annotated TRANSIT 1..27 instead.
Scored against panels of ten human TRANSIT-annotated and ten human SIGNAL-annotated proteins
(the latter weighted towards plasma apolipoproteins), the MIC26 1-25 segment behaves like a
presequence, not a signal peptide
[file:human/APOO/APOO-bioinformatics/RESULTS.md "On 4 of the 5 metrics the MIC26 1–25 segment sits closer to the mitochondrial-presequence panel than to the secretory-signal-peptide panel."].
The decisive feature is the missing hydrophobic core
[file:human/APOO/APOO-bioinformatics/RESULTS.md "Every one of the ten signal peptides in the panel reaches a 7-residue"]
— MIC26 reaches only +1.70 on that scale, below the entire secretory panel, while its
hydrophobic moment (0.602) is at the mitochondrial panel mean (0.61) and 5.8 SD from the
secretory mean.

Honest caveat recorded in RESULTS.md: MIC26 has only one Arg in the segment, unlike classic
Arg-rich presequences. But MIC27 has the same Arg deficit and UniProt still calls its
N-terminus a transit peptide, so within this family the Arg metric does not separate the
classes. Neither protein has Arg at -2/-3.

This is corroboration, not proof — the knockout/MS evidence in PMID:37279200 is what settles
it. What the sequence analysis adds is a mechanism for the historical error: a
sequence-analysis SIGNAL call on an N-terminus that is really a mitochondrial targeting
sequence, on a protein whose amphipathic helices made "apolipoprotein" a plausible name.


2. What MIC26 actually does

2.1 Position in the complex

MICOS has seven mammalian subunits in two subcomplexes bridged by MIC13: MIC60-MIC19-MIC25 and
MIC10-MIC26-MIC27. MIC26 sits in the MIC10 subcomplex. The MICOS complex connects through
MIC60 to SAM50 in the outer membrane to form the ~2 MDa MIB complex, and complexome profiling
resolves the assembly ladder
PMID:26477565.
MIC26 and MIC27 are the family's late additions in evolution
PMID:26477565,
which is exactly what PANTHER encodes: PTHR14564 is named "MICOS COMPLEX SUBUNIT MIC26 /
MIC27 FAMILY MEMBER" and every one of the nine UniProt-reviewed members in the committed
PTHR14564-entries.csv is a MIC26 or MIC27 orthologue.

2.2 Crista junction formation — core, but partially redundant with MIC27

Three human datasets, with a real tension between them:

The knockout data break the tie in favour of a real but redundant contribution: MIC26 alone is
dispensable for complex integrity
PMID:32788226
yet its loss still measurably costs crista junctions. Human genetics agrees: a missense
I117T
PMID:32439808
and a C-terminal nonsense E178*
PMID:37649161
both cause mitochondrial disease through cristae disruption.

So GO:0042407 cristae formation is core for MIC26 specifically, not merely inherited from the
complex — the single-gene knockout phenotype is the evidence that distinguishes the two.

2.3 Cardiolipin: regulate, yes; bind, not demonstrated for MIC26

This is the easiest place on this gene to over-annotate, because the paralogue really does bind
cardiolipin and the two are routinely discussed together.

No GO:1901612 cardiolipin binding annotation is proposed for APOO. One NEW row is
proposed: GO:1900208 regulation of cardiolipin metabolic process, IMP, on the human
single-knockout lipidomics.

2.4 MIC10 oligomer regulation — yeast, so far

PMID:29733859
That is Saccharomyces cerevisiae Mic26. The human counterpart is the reciprocal protein-level
regulation seen by Koob and Anand (knocking out one raises the other, post-transcriptionally),
which is not the same claim. Not annotated on human APOO.

2.5 Mitochondrial morphology — MIC26-specific, mechanism unknown

MIC26 knockout fragments mitochondria in human HAP1 cells and MIC27 knockout does not
PMID:32788226,
with fusion machinery unaffected. The authors decline to interpret it
PMID:32788226.
Mouse macrophage knockout reaches the same phenotype by a different route
PMID:37995600.
Recorded as a knowledge gap and a suggested experiment rather than a GO annotation: it is a
reproducible steady-state morphology phenotype whose mechanistic relation to MIC26's structural
role is exactly what the primary authors say is unknown.

2.6 Physiology (non-core)

Transgenic human APOO in mouse heart promotes lipotoxic cardiomyopathy PMID:24743151;
adipocyte-specific knockout impairs BAT thermogenesis
PMID:37088120;
macrophage-specific knockout increases efferocytosis PMID:37995600. These are mouse,
tissue-specific, downstream of the cristae/OXPHOS defect, and none is annotated in the current
GOA set. They are not proposed as new human annotations.


3. The two IBA rows

Family PAINT slice fetched to interpro/panther/PTHR14564/PTHR14564-paint.tsv. The family has
one PAINT node carrying two IBD annotations — exactly the two IBAs on APOO:

node GO term aspect IBD seeds date
PTN001803267 GO:0061617 MICOS complex C FB:FBgn0038400, UniProtKB:Q6UXV4, UniProtKB:Q9BUR5 2024-07-30
PTN001803267 GO:0042407 cristae formation P UniProtKB:Q9BUR5 2018-05-10

Donors resolved:

Node placement: all nine UniProt-reviewed members in PTHR14564-entries.csv are MIC26 or
MIC27 orthologues (human/mouse/bovine MIC26; human/mouse/bovine/orangutan/chicken MIC27;
C. elegans moma-1). Both human paralogues and the single fly gene receive IBA from
PTN001803267 (checked in QuickGO), so the node sits at or near the family root, before the
MIC26/MIC27 duplication.
APOO is inside the inheriting clade with its own experimental evidence for both terms, and
there is no IRD/IKR anywhere in the slice. Both IBAs: NO_FAILURE_CORE.

The cristae-formation IBD is seeded by a single gene — human APOO itself. Per
projects/IBA_REVIEW.md, a short donor list is not weak evidence; the claim is about where the
function arose, and the curator had the whole tree. Nothing in the family contradicts it, and
the fly and worm members are cristae-shaping proteins.


4. The SAM complex row is a complexome-profiling projection

GO:0001401 SAM complex, HDA, PMID:26477565. Queried QuickGO by
reference=PMID:26477565&goId=GO:0001401: 12 entities, resolved individually —
MIC10 (Q5TGZ0), MIC13 (Q5XKP0), MIC19 (Q9NX63), MIC25 (Q9BRQ6), MIC26 (Q9BUR5), MIC27 (Q6UXV4),
MIC60 (Q16891), SAMM50 (Q9Y512), MTX1 (Q13505), MTX2 (O75431), MTX3 (Q5HYI7), HSPA9 (P38646).
That is the whole MIB complex, not the SAM complex: everything that co-migrated in one
complexome profile received the SAM term. The SAM complex is defined as "A large complex of the
mitochondrial outer membrane"; MIC26 is a single-pass inner-membrane protein. The same
reference already produces the correct GO:0140275 MIB complex row for APOO, so nothing is
lost by removing the SAM row.


5. GO term definitions consulted (QuickGO /ontology/go/terms/<id>/complete)

InterPro2GO (GO_REF:0000002): IPR019166 "MICOS complex subunit MIC26/MIC27" and IPR033182
"MICOS complex subunit MIC26/MIC27, animal" both map to exactly GO:0042407 + GO:0061617.
Correct family, correct terms.

ARBA (GO_REF:0000120): ARBA00026962 asserts GO:0005739; it has 380 condition sets, and
condition set 26 is InterPro id IPR019166 + taxon Eukaryota. APOO satisfies it.


6. The affinage record

self_evaluation_pairwise: win, faith_pct: 100.0, trust gates clear (.affinage.log:
"APOO: trust gates clear"). The narrative is about the right protein — MIC26, Q9BUR5 — with no
symbol collision, and it correctly foregrounds the 2023 refutation of the secreted isoform,
which is the single most important fact about this gene's annotations. Substantively strong.

Two defects found:

  1. A wrong PMID, used twice. Affinage cites PMID:26217776 alongside PMID:25764979 for the
    MIC26 crista-junction and MIC26/MIC27-antagonism findings, labelling it Biochimica et
    biophysica acta
    . PMID:26217776 is in fact "Mass spectrometry analysis of K63-ubiquitinated
    targets in response to oxidative stress" (Silva & Vogel, Data Brief 2015) — an unrelated
    yeast ubiquitination dataset. The intended paper is almost certainly PMID:26217777,
    "Data supporting the role of the non-glycosylated isoform of MIC26 in determining cristae
    morphology" (Koob, Barrera, Anand, Reichert, Data Brief 2015) — one digit away, correct
    authors, correct content. Verified by fetching both. Nothing in this review is cited to
    26217776.
  2. Imported GO grounding not reused. Affinage's mechanism_profile proposes
    GO:0005198 structural molecule activity and GO:0005739 mitochondrion. Both were
    re-derived here from the primary literature and term definitions rather than imported; they
    happen to agree, which is reassuring but was not assumed.

What affinage missed (found by independent PubMed E-utilities searches on APOO AND mitochondria, MIC26 MICOS, apolipoprotein O cristae — Europe PMC REST was unavailable):


7. Reconciliation checks run

8. Open items flagged for UniProt / GOA